Deliver Actionable Solutions for Patients
As a patient led organization ARC has firsthand knowledge of how amyloidosis affects our community. We engage scientists, policymakers and government regulators as partners in our efforts to breakdown barriers to research and drug development.
ARC is focused on developing the tools and strategies to ensure patient needs are effectively addressed across the entire amyloidosis drug development continuum. The collective patient experience is critical to inform amyloidosis research and improve patient outcomes.
Find out more about how you might become involved.